We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetards Regulatory News (PEG)

Share Price Information for Petards (PEG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.75
Bid: 7.50
Ask: 8.00
Change: 0.00 (0.00%)
Spread: 0.50 (6.667%)
Open: 7.75
High: 7.75
Low: 7.75
Prev. Close: 7.75
PEG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

8 Sep 2015 07:00

RNS Number : 3261Y
Petards Group PLC
08 September 2015
 

8 September 2015

PETARDS GROUP PLC

INTERIM RESULTS ANNOUNCEMENT

 

Petards Group plc ('Petards'), the AIM quoted developer of advanced security and surveillance systems, reports its interim results for the six months to 30 June 2015.

 

Key points:

 

· Operational

o June order book remained strong at £19 million providing good revenue cover for the second half of 2015 and beyond

§ Circa 40% of order book currently scheduled for delivery in the second half of 2015

§ H1 2015 highlights included:

· Over £2.5 million of orders for Petards' eyeTrain CCTV systems under the framework agreements held with Siemens and Hitachi, and a new project from Bombardier

· Strong recurring revenue streams for eyeTrain spares and support

· Financial

o Strong results for the six months to 30 June 2015

§ Higher margin revenues than 2014 totaled £6.1 million (2014: £7.2 million)

· Gross margins of 36.4% (2014: 27.4%)

§ 39% increase in EBITDA to £609,000 (2014: £441,000)

§ Operating profit increased to £436,000 (2014: £346,000)

§ 30% increase in profit after tax to £356,000 (2014: £273,000)

 

o Finance

§ Cash inflow from operating activities £558,000 (2014: £181,000)

§ Cash at 30 June 2015 £2.0 million (31 Dec 2014: £1.4 million) with no bank debt

§ Basic EPS up 30% to 1.03p per share (2014: 0.79p per share)

§ Diluted EPS up 23% to 0.76p per share (2014: 0.62p per share)

 

Commenting on the current outlook, Raschid Abdullah, Chairman, said:

 

"The continued strength of the order book at 30 June provides good support for revenues for the second half of 2015, with around 40% currently scheduled for delivery before the year end, giving the Board confidence for a satisfactory outcome for the year."

 

 

 

Contacts:

Petards Group plc

www.petards.com

 

Raschid Abdullah, Chairman

Mb: 07768 905004

 

Andy Wonnacott, Finance Director

Tel: 0191 420 3000

 

 

WH Ireland Limited, Nomad and Joint Broker

www.wh-ireland.co.uk

 

Mike Coe, Ed Allsopp

Tel: 0117 945 3470

 

 

Hybridan LLP, Joint Broker

www.hybridan.com

Claire Louise Noyce

 

Tel: 020 3764 2341

claire.noyce@hybridan.com

 

St Brides Partners Limited, Financial PR

www.stbridespartners.co.uk

Elisabeth Cowell, Charlotte Heap

Tel: 020 7236 1177

 

Chairman's Statement

 

I am pleased to report that the results for the Group for the six months ended 30 June 2015 show continued improvement in the Company's trading performance. This reflects significant increases in margins, profitability and cash flows over the comparable period in 2014 resulting in greater Balance Sheet strength.

 

The Group serves three sectors, those of:

· Transport (Rail - software driven video systems mounted in-train and externally and automatic passenger counting (APC) systems sold under eyeTrain brand)

· Emergency Services (Mobile speed enforcement and ANPR systems predominantly to Law Enforcement Agencies sold under the ProVida brand)

· Defence (Electronic defensive countermeasures and mobile radio systems predominantly to the UK Ministry of Defence ("MOD"))

The overall order book at the end of June was just under £19 million with the level of the Group's eyeTrain products order book maintained following a number of repeat orders from train builders.

 

Operating review

 

During the period the Group secured a number of new orders for its eyeTrain systems. In addition to the previously announced order worth in excess of £1.5 million secured in March 2015 from Siemens Mobility Germany for Driver Only Operation (DOO) systems and saloon CCTV, the Group was also awarded further orders totalling £1 million by Bombardier Transportation and Hitachi. The Bombardier order is for further sets of equipment for fitment to Electrostar trains for delivery in 2016 and a second order by Hitachi under the framework agreement awarded in August 2013 for the supply of APC systems for its Class 800 trains for the Intercity Express Programme. These APC systems will be fitted to trains to be built at Hitachi's recently opened rail vehicle manufacturing facility in Newton Aycliffe for use on the East Coast Main Line with delivery scheduled for 2017/18.

 

The growing installed base of eyeTrain is leading to an increase in the levels of recurring revenues from spares and support as wear and tear take their effect on earlier installations, with revenues for the first half of 2015 exceeding expectations. It is anticipated that this trend will continue and increasingly become a significant contributor to the Group's revenues as the existing installed base becomes older, the current order book is delivered and as warranties progressively expire. To support this growth some additional investment in both personnel and systems was made during the period.

 

The Board and management remain conscious that the success of the business is dependent upon understanding and meeting its customers' requirements without compromising quality, in particular in the area of interfacing software. To this end, products continue to be reviewed for improvement from a cost, functionality and reliability perspective.

 

The largest contributor to defence revenues in the first half year was the modification programme for countermeasures equipment fitted to certain aircraft within the MOD's fleet. The £4.5 million project, which is now over 40% complete, is running to schedule and in line with budget with completion scheduled for the second half of 2016.

 

While performance from the defence business was satisfactory in the first half of the year, order intake to date has been slower than anticipated albeit there have been signs of improvement in recent weeks. In July the MOD awarded the Group a £0.3 million contract spread over three years for the provision of specialist engineering support services at certain MOD bases in Europe.

 

Although the Group's activities within the context of the UK defence sector are relatively small, management believes that with so much unrest in various parts of the world, in particular in the Middle East, demand for its defence related products and services, while unpredictable as to timing, will continue at acceptable levels.

 

The Emergency Services part of the Group's business, which has traditionally been the smallest revenue producer, reflecting the nature of its product range, has been a good contributor to the Group's operating profit and remains so. Revenue for the first half of the year was significantly ahead of the corresponding period last year following the delivery of a long awaited, substantial spares order from an overseas government.

 

While order intake to date for ProVida products has been slower than anticipated, there exist a good number of active prospects for the second half of 2015 into 2016. This represents a good area of business for the Group with interest from the UK market showing signs of improving and the potential to tackle export markets which have lapsed over recent years.

 

As indicated at the time of the publication of the results for 2014, following the heavy investment in product development in that year, in particular in the area of transport, investment will be substantially lower in 2015. However, the Group continues to work on developing and increasing the breadth and capability of its product range as part of its programme of seeking constant improvement.

 

Financial review

 

Revenues at £6.1 million for the six months ended 30 June 2015 were down on the corresponding period last year (2014: £7.2 million) as 2014 included £3 million of lower margin equipment deliveries for the MOD's SMRE project whereas the six month period to June 2015 benefitted from a larger proportion of higher margin eyeTrain and ProVida products and services, both of which showed growth over the corresponding period last year.

 

 Revenues from eyeTrain products were ahead of expectations principally due to much stronger recurring revenues for spares and support which contributed to the achievement of higher margins. Similarly the spares order worth in the region of £0.4 million from an overseas government for their existing ProVida mobile ANPR systems provided a boost to revenues and margins for Emergency Services. The effect of the above was to substantially increase gross margins for the Group to 36% (June 2014: 27%).

 

While administrative expenses rose to £1.8 million (June 2014: £1.6 million) half of this increase was due to a higher charge for amortisation arising from product development costs capitalised in 2014. Earnings before interest, tax, depreciation and amortisation (EBITDA) improved by 38% to £609,000 (June 2014: £441,000) and operating profit by 26% to £436,000 (June 2014: £346,000).

 

After net financial expenses of £80,000 (June 2014: £73,000) and there being no tax charge, the Group recorded a profit after tax of £356,000 (June 2014: £273,000), an improvement of 30% on the corresponding period last year, resulting in a further strengthening of the balance sheet.

 

The Group also recorded strong cash generation during the period. Net cash inflow from operating activities was £558,000 (June 2014: £181,000) with working capital levels remaining comparable to those at both June and December 2014. Cash balances at 30 June 2015 increased to £2.0 million up from £1.4 million at 31 December 2014 and after providing for outstanding long term convertible loan notes that do not mature until 2018, free net cash totalled £0.4 million (December 2014: £0.1 million net debt).

 

The Board is conscious of the value of dividends to shareholders. However, at this juncture, the lack of distributable reserves prevents payments of dividends.

 

Shortly after the period end the Group increased its available funding by entering into a £1.1 million overdraft and trade finance facility with Santander UK plc. While it does not presently envisage utilising the overdraft element of this facility, having it provides the Board with added flexibility in the financing of the Group.

 

Outlook

 

The objective of the Board remains that of building a sustainable business built on solid foundations able to adapt to technological changes and the constantly changing business and operational environments while satisfying the requirements of its customers.

 

Profitability, strong operational cash flow and the strengthening of the Balance Sheet have enabled the Board to make investment decisions in support of this objective.

 

The Board believes that the Company and its management are well positioned to take on further challenges whether these are driven by organic growth through product and market development, acquisition of businesses and/or access to products which will enhance the existing business model or broaden the corporate identity of the Group; or a combination of all three.

 

The continued strength of the order book at 30 June provides good support for revenues for the second half of 2015, with around 40% currently scheduled for delivery before the year end, giving the Board confidence for a satisfactory outcome for the year.

 

Raschid Abdullah

8 September 2015

 

Condensed Consolidated Income Statement

for the six months ended 30 June 2015

 

Note

Unaudited

6 monthsended30 June2015

Unaudited

6 monthsended30 June2014

Audited

yearended31 December 2014

£000

£000

£000

Revenue

6,067

7,163

13,462

Cost of sales

(3,860)

(5,202)

(9,370)

Gross profit

2,207

1,961

4,092

Administrative expenses

(1,771)

(1,615)

(3,323)

Operating profit

436

346

769

Analysed as:

Earnings before interest, tax, depreciation and amortisation ('EBITDA')

609

441

1,015

Depreciation and amortisation

(172)

(95)

(246)

Share based payments

(1)

-

-

436

346

769

 

Financial income

 

1

 

2

 

3

Financial expenses

2

(81)

(75)

(152)

Profit before tax

356

273

620

Income tax

3

-

-

-

Profit for the period attributable to equity

shareholders of the company

 

356

 

273

 

620

Basic earnings per share (pence)

4

1.03

0.79

1.80

Diluted earnings per share (pence)

4

0.76

0.62

1.37

The above results are derived from continuing operations.

Condensed Consolidated Statement of Comprehensive Income

for the six months ended 30 June 2015

Unaudited

6 months ended

30 June

2015

Unaudited

6 months ended

30 June 2014

Audited

year

ended

31 December 2014

£000

£000

£000

Profit for period

356

273

620

Other comprehensive income

Currency translation on foreign currency net investments

-

-

-

Total comprehensive income for the period

356

273

620

 

 

 

Condensed Consolidated Statement of Changes in Equity

for the six months ended 30 June 2015

 

 

Share

capital

 

Share

premium

 

Merger

reserve

Equity

reserve

 

Retained

earnings

Currency

translation

differences

 

Total

equity

£000

£000

£000

£000

£000

£000

£000

Balance at 1 January 2014 (audited)

6,645

25,153

1,075

206

(31,132)

(211)

1,736

Profit for the period

-

-

-

-

273

-

273

Other comprehensive income

-

-

-

-

-

-

-

Total comprehensive income for the

 period

-

-

-

-

273

-

273

Conversion of convertible loan

 notes

3

17

-

(1)

1

-

20

Balance at 30 June 2014 (unaudited)

6,648

25,170

1,075

205

(30,858)

(211)

2,029

Balance at 1 January 2014 (audited)

6,645

25,153

1,075

206

(31,132)

(211)

1,736

Profit for the year

-

-

-

-

620

-

620

Other comprehensive income

-

-

-

-

-

-

-

Total comprehensive income for the

 year

 

-

 

-

 

-

 

-

 

620

 

-

 

620

Conversion of convertible loan

 notes

4

23

-

(2)

2

-

27

Exercise of share options

2

16

-

-

-

-

18

Balance at 31 December 2014 (audited)

6,651

25,192

1,075

204

(30,510)

(211)

2,401

Balance at 1 January 2015 (audited)

6,651

25,192

1,075

204

(30,510)

(211)

2,401

Profit for the period

-

-

-

-

356

-

356

Other comprehensive income

-

-

-

-

-

-

-

Total comprehensive income for the

 period

-

-

-

-

356

-

356

Equity-settled share based payments

-

-

-

-

1

-

1

Conversion of convertible loan

 notes

1

11

-

(1)

1

-

12

Balance at 30 June 2015 (unaudited)

6,652

25,203

1,075

203

(30,152)

(211)

2,770

 

Condensed Consolidated Balance Sheet

at 30 June 2015

Unaudited

30 June2015

Unaudited

30 June2014

Audited

31 December 2014

ASSETS

£000

£000

£000

Non-current assets

Property, plant and equipment

212

170

187

Goodwill

401

401

401

Development costs

983

618

1,103

Deferred tax assets

514

647

516

2,110

1,836

2,207

Current assets

Inventories

1,864

1,900

1,439

Trade and other receivables

2,382

2,283

2,982

Cash and cash equivalents - escrow deposits

-

35

54

Cash and cash equivalents

1,968

1,508

1,434

6,214

5,726

5,909

Total assets

8,324

7,562

8,116

EQUITY AND LIABILITIES

Equity attributable to equity holders of the parent

Share capital

6,652

6,648

6,651

Share premium

25,203

25,170

25,192

Equity reserve

203

205

204

Merger reserve

1,075

1,075

1,075

Currency translation reserve

(211)

(211)

(211)

Retained earnings deficit

(30,152)

(30,858)

(30,510)

Total equity

2,770

2,029

2,401

Non-current liabilities

Interest-bearing loans and borrowings

1,528

1,515

1,524

Deferred tax liabilities

100

124

100

1,628

1,639

1,624

Current liabilities

Trade and other payables

3,926

3,894

4,091

3,926

3,894

4,091

Total liabilities

5,554

5,533

5,715

Total equity and liabilities

8,324

7,562

8,116

 

Condensed Consolidated Statement of Cash Flows

for the six months ended 30 June 2015

Unaudited

6 months ended30 June2015

Unaudited

6 months ended30 June2014

Audited

yearended31 December 2014

£000

£000

£000

Cash flows from operating activities

Profit for the period

356

273

620

Adjustments for:

Depreciation

26

24

48

Amortisation of intangible assets

147

71

198

Equity settled share-based payment expenses

1

-

-

Financial income

(1)

(2)

(3)

Financial expense

81

75

152

Income tax charge

-

-

-

Operating cash flows before movement in working capital

610

441

1,015

Change in trade and other receivables

600

(1,336)

(2,035)

Change in inventories

(425)

(121)

340

Change in trade and other payables

(160)

1,206

1,340

Cash generated from operations

625

190

660

Interest received

1

2

3

Interest paid

(68)

(49)

(110)

Income tax received

-

38

208

Net cash generated from operating activities

558

181

761

Cash flows from investing activities

Acquisition of property, plant and equipment

(51)

(29)

(70)

Capitalised development expenditure

(27)

(49)

(661)

Cash deposits held in escrow

54

(35)

(54)

Net cash used in investing activities

(24)

(113)

(785)

Cash flows from financing activities

Proceeds from exercise of share options

-

-

18

Net cash generated from financing activities

-

-

18

Net increase/(decrease) in cash and cash equivalents

534

68

(6)

Cash and cash equivalents at start of period

1,434

1,440

1,440

Cash and cash equivalents at end of period

1,968

1,508

1,434

Cash and cash equivalents comprise:

Cash and cash equivalents per balance sheet

1,968

1,508

1,434

Notes

1 Basis of preparation

The interim financial information set out in this statement for the six months ended 30 June 2015 and the comparative figures for the six months ended 30 June 2014 are unaudited. This financial information does not constitute statutory accounts as defined in Section 435 of the Companies Act 2006.

 

The comparative figures for the financial year ended 31 December 2014 are not the Company's statutory accounts for that financial year. Those accounts have been reported on by the Company's auditors and delivered to the Registrar of Companies. The report of the auditors was (i) unqualified, (ii) did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 498 (2) or (3) of the Companies Act 2006.

 

This interim statement, which is neither audited nor reviewed, has been prepared in accordance with the measurement and recognition criteria of International Financial Reporting Standards (IFRS) as adopted by the EU. It does not include all the information required for the full annual financial statements, and should be read in conjunction with the financial statements of the Group as at and for the year ended 31 December 2014. As permitted, this interim statement has been prepared in accordance with AIM Rules for Companies and is not required to comply with IAS 34 'Interim Financial Reporting' to maintain compliance with IFRS.

The accounting policies applied in preparing these interim financial statements are the same as those applied in the preparation of the annual financial statements for the year ended 31 December 2014, as described in those financial statements other than standards, amendments and interpretations which became effective after 1 January 2015 and were adopted by the Group. These have had no significant impact on the Group's profit for the period or equity. The Board approved these interim financial statements on 7 September 2015.

 

Copies of this interim statement will be available on the Company's website (www.petards.com) and from the Company's registered office at 390 Princesway, Team Valley, Gateshead, Tyne and Wear, NE11 0TU.

 

2 Financial expenses

 

Unaudited

6 months ended

 30 June

2015

£000

Unaudited

6 months ended

30 June

2014

£000

Audited

year ended

31 December 2014

£000

Interest expense on financial liabilities at amortised cost:

- Convertible loan notes at 7% p.a. (cash)

- Convertible loan notes amortisation (non-cash)

- Other (cash)

 

56

16

1

 

59

15

1

 

116

31

3

Net foreign exchange loss

8

-

2

Financial expenses

81

75

152

3 Taxation

No provision for taxation has been made in the Condensed Consolidated Income Statement for the six months to 30 June 2015 based on the estimated tax provision required for the year ending 31 December 2015. No provision was required in the six months to 30 June 2014.

 

 

 

 

4 Earnings per share

Basic earnings per share

Basic earnings per share is calculated by dividing the profit for the period attributable to the shareholders by the weighted average number of shares in issue.

Unaudited6 monthsended30 June2015

Unaudited6 months ended30 June2014

Auditedyearended31 December 2014

Earnings

Profit for the period (£000)

356

273

620

Number of shares

Weighted average number of ordinary shares ('000)

34,629

34,347

34,514

Diluted earnings per share

Diluted earnings per share assumes conversion of all potentially dilutive ordinary shares, which arise from both convertible loan notes and share options, and is calculated by dividing the adjusted profit for the period attributable to the shareholders by the assumed weighted average number of shares in issue. The adjusted profit for the period comprises the profit for the period attributable to the shareholders after adding back the interest on convertible loan notes for the period.

 

Unaudited6 monthsended30 June2015

Unaudited6 months ended30 June2014

Auditedyearended31 December 2014

Adjusted earnings

Profit for the period (£000)

425

347

769

Number of shares

Weighted average number of ordinary shares ('000)

55,879

55,983

55,931

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR ZDLFBEKFEBBX
Date   Source Headline
23rd Feb 20247:00 amRNSHolding(s) in Company
19th Feb 20247:00 amRNSContract Win
14th Feb 20247:00 amRNSContract Extension
30th Jan 20247:00 amRNSContract Win
25th Jan 20247:00 amRNSTrading Update
4th Jan 20245:40 pmRNSHolding(s) in Company
3rd Jan 20245:21 pmRNSHolding(s) in Company
19th Dec 202310:55 amRNSDirectorate Change
14th Dec 202311:24 amRNSHolding(s) in Company
13th Dec 202311:43 amRNSHolding(s) in Company
7th Dec 20234:19 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSDirector Appointment
26th Sep 20237:00 amRNSHalf-year Report
14th Jun 20232:46 pmRNSResult of AGM
26th May 202312:26 pmRNSHolding(s) in Company
19th May 20233:08 pmRNSPosting of Annual Report and Notice of AGM
9th May 20237:00 amRNSFinal Results
1st Feb 20237:00 amRNSDirector Appointment
16th Jan 20232:56 pmRNSHolding(s) in Company
15th Sep 20227:00 amRNSHalf-year Report
8th Jun 20222:58 pmRNSResult of AGM
13th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFinal Results
3rd Dec 20212:33 pmRNSHolding(s) in Company
30th Nov 20217:00 amRNSTransaction in Own Shares
29th Nov 20219:05 amRNSSecond Price Monitoring Extn
29th Nov 20219:00 amRNSPrice Monitoring Extension
9th Nov 20212:56 pmRNSHolding(s) in Company
23rd Sep 20217:00 amRNSHalf-year Report
22nd Jul 20212:40 pmRNSResult of AGM
1st Jul 20217:00 amRNSContract Award
28th Jun 20217:00 amRNSPosting of Accounts and Notice of AGM
24th Jun 20217:00 amRNSContract
28th May 20217:00 amRNSFinal Results
11th Feb 20217:00 amRNSTrading Update
8th Jan 20217:00 amRNSStmnt re Share Price Movement
9th Dec 20207:00 amRNSContract win
21st Oct 20207:00 amRNSContract win
14th Oct 20207:00 amRNSContract Win
24th Sep 20207:00 amRNSInterim Results
3rd Aug 20207:00 amRNSeyeCraft360 British Army trial success
24th Jul 20204:36 pmRNSHolding(s) in Company
23rd Jul 202011:32 amRNSResult of AGM
26th Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
18th Jun 20207:00 amRNSFinal Results
27th May 20209:54 amRNSServices Support Agreement
12th May 20207:00 amRNSServices Support Agreement
7th May 20207:00 amRNSAcquisition of New Product Line
28th Apr 202011:10 amRNSHolding(s) in Company
24th Apr 20207:00 amRNSCOVID-19 Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.